PTC Therapeutics | PTCT - Cost Of Sales



PTC Therapeutics reported $15.48M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Acadia Pharmaceuticals USD 20.73M 342K Jun/2025
Alnylam Pharmaceuticals USD 142.95M 71.91M Jun/2025
Amgen USD 3.01B 406M Jun/2025
Biogen USD 605M 24.3M Jun/2025
BioMarin Pharmaceutical USD 154.94M 3.38M Jun/2025
Cytokinetics 112.55M 12.71M Jun/2025
Daiichi Sankyo JPY 92.35B 1.99B Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
Incyte USD 78.77M 10.96M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
Novartis USD 3.32B 95M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
PTC Therapeutics USD 15.48M 2.62M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sarepta Therapeutics USD 153.22M 15.66M Jun/2025
TG Therapeutics USD 18.94M 3.4M Jun/2025
Ultragenyx Pharmaceutical USD 23M 5.66M Jun/2025
Vertex Pharmaceuticals USD 407.5M 44.5M Jun/2025
Xencor 61.66M 50.95M Jun/2025